Hariharan Subramanian
Co-founder and Chief Technology Officer
pharmaceutical sciences
NanoCytomics
United States of America
Biography
Dr. Subramanian was one of the original developers of partial wave spectroscopic (PWS) microscopy, the company’s foundational technology platform. He is currently spearheading the company’s clinical implementation of the technology for risk-stratification applications in colon, lung, prostate, esophageal, ovarian and pancreatic cancers. Dr. Subramanian has considerable experience in the areas of biomedical optics, cancer biology and clinical research, with numerous publications appearing in leading peer-reviewed journals. Dr. Subramanian has received multiple research and business challenge awards, and he serves as a technical reviewer for several scientific and medical journals. He received his PhD in biomedical engineering from Northwestern University.
Research Interest
